BtX-13 (EpimedX)

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameBtX-13 (EpimedX)
Drug Alias NameBtX-13
ClassificationBiologics > Protein drugs
Mechanisms of ActionFetal hemoglobin agonists
TargetsFetal hemoglobin
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpimedX LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpimedX LLC
Active IndicationsN/A
Inactive Indicationsbeta-Thalassemia

Other Information

ATC CodeN/A
Related LinksN/A